Portal de Periódicos da CAPES

Unsupervised Walking Activity Assessment Reveals COVID ‐19 Impact on Parkinson's Disease Patients

2021; Wiley; Volume: 36; Issue: 3 Linguagem: Inglês

10.1002/mds.28514

1531-8257

Diogo Vila‐Viçosa, Ana Cristina Fernandes Clemente, Filipa Pona‐Ferreira, Mariana Leitão, Raquel Bouça‐Machado, Linda Azevedo Kauppila, Rui M. Costa, Ricardo Matias, Joaquim J. Ferreira,

Transcranial Magnetic Stimulation Studies

Movement DisordersVolume 36, Issue 3 p. 531-532 Letters: New Observation Unsupervised Walking Activity Assessment Reveals COVID-19 Impact on Parkinson's Disease Patients Diogo Vila-Viçosa PhD, Diogo Vila-Viçosa PhD orcid.org/0000-0001-6620-0484 Kinetikos, Coimbra, PortugalSearch for more papers by this authorAna Clemente MSc, Ana Clemente MSc Kinetikos, Coimbra, PortugalSearch for more papers by this authorFilipa Pona-Ferreira, Filipa Pona-Ferreira orcid.org/0000-0002-0263-8521 CNS-Campus Neurológico Sénior, Torres Vedras, PortugalSearch for more papers by this authorMariana Leitão, Mariana Leitão orcid.org/0000-0002-2368-9360 CNS-Campus Neurológico Sénior, Torres Vedras, PortugalSearch for more papers by this authorRaquel Bouça-Machado MSc, Raquel Bouça-Machado MSc orcid.org/0000-0003-3756-2763 CNS-Campus Neurológico Sénior, Torres Vedras, Portugal Instituto de Medicina Molecular João Lobo Antunes, Lisbon, PortugalSearch for more papers by this authorLinda A. Kauppila MD, MSc, Linda A. Kauppila MD, MSc orcid.org/0000-0001-8463-5625 Department of Neurosciences and Mental Health, Neurology, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, PortugalSearch for more papers by this authorRui M. Costa DVM, PhD, Rui M. Costa DVM, PhD orcid.org/0000-0003-0495-8374 Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal Zuckerman Mind Brain Behavior Institute, Columbia University, New York, New York, USASearch for more papers by this authorRicardo Matias PhD, Corresponding Author Ricardo Matias PhD [email protected] orcid.org/0000-0003-1785-2640 Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal Champalimaud Clinical Centre, Champalimaud Centre for the Unknown, Lisbon, Portugal Human Movement Analysis Lab, Escola Superior Saúde – Instituto Politécnico de Setúbal, Setúbal, Portugal Correspondence to: Dr. Ricardo Matias, Champalimaud Center for the Unknown. Av. De Brasília, 1400-038 Lisbon, Portugal; E-mail: [email protected]Search for more papers by this authorJoaquim J. Ferreira MD, PhD, Joaquim J. Ferreira MD, PhD orcid.org/0000-0003-3950-5113 CNS-Campus Neurológico Sénior, Torres Vedras, Portugal Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, PortugalSearch for more papers by this author Diogo Vila-Viçosa PhD, Diogo Vila-Viçosa PhD orcid.org/0000-0001-6620-0484 Kinetikos, Coimbra, PortugalSearch for more papers by this authorAna Clemente MSc, Ana Clemente MSc Kinetikos, Coimbra, PortugalSearch for more papers by this authorFilipa Pona-Ferreira, Filipa Pona-Ferreira orcid.org/0000-0002-0263-8521 CNS-Campus Neurológico Sénior, Torres Vedras, PortugalSearch for more papers by this authorMariana Leitão, Mariana Leitão orcid.org/0000-0002-2368-9360 CNS-Campus Neurológico Sénior, Torres Vedras, PortugalSearch for more papers by this authorRaquel Bouça-Machado MSc, Raquel Bouça-Machado MSc orcid.org/0000-0003-3756-2763 CNS-Campus Neurológico Sénior, Torres Vedras, Portugal Instituto de Medicina Molecular João Lobo Antunes, Lisbon, PortugalSearch for more papers by this authorLinda A. Kauppila MD, MSc, Linda A. Kauppila MD, MSc orcid.org/0000-0001-8463-5625 Department of Neurosciences and Mental Health, Neurology, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, PortugalSearch for more papers by this authorRui M. Costa DVM, PhD, Rui M. Costa DVM, PhD orcid.org/0000-0003-0495-8374 Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal Zuckerman Mind Brain Behavior Institute, Columbia University, New York, New York, USASearch for more papers by this authorRicardo Matias PhD, Corresponding Author Ricardo Matias PhD [email protected] orcid.org/0000-0003-1785-2640 Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal Champalimaud Clinical Centre, Champalimaud Centre for the Unknown, Lisbon, Portugal Human Movement Analysis Lab, Escola Superior Saúde – Instituto Politécnico de Setúbal, Setúbal, Portugal Correspondence to: Dr. Ricardo Matias, Champalimaud Center for the Unknown. Av. De Brasília, 1400-038 Lisbon, Portugal; E-mail: [email protected]Search for more papers by this authorJoaquim J. Ferreira MD, PhD, Joaquim J. Ferreira MD, PhD orcid.org/0000-0003-3950-5113 CNS-Campus Neurológico Sénior, Torres Vedras, Portugal Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, PortugalSearch for more papers by this author First published: 11 January 2021 https://doi.org/10.1002/mds.28514Citations: 4 Relevant conflicts of interest/financial disclosures: R.M.C. as a shareholder position at Kinetikos. R.M. is a shareholder of a Kinetikos' affiliated company. D.V.V. and A.C. are employees at Kinetikos. The other authors have no conflicts of interest to declare. Funding agencies: No specific funding was received for this work. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Schirinzi T, Cerroni R, Di Lazzaro G, et al. Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy. Neurol Sci 2020; 3: 1–3. Google Scholar 2Brown E, Chahine L, Goldman S, et al. The effect of the COVID-19 pandemic on people with Parkinson's disease. J Parkinsons Dis 2020; 10(4): 1365–1377. 10.3233/JPD-202249 CASPubMedWeb of Science®Google Scholar 3Warmerdam E, Hausdorff J, Atrsaei S, et al. Long-term unsupervised mobility assessment in movement disorders. Lancet Neurol 2020; 19(5): 462–470. 10.1016/S1474-4422(19)30397-7 PubMedWeb of Science®Google Scholar 4van Nimwegen M, Speelman AD, Overeem S, et al. Promotion of physical activity and fitness in sedentary patients with Parkinson's disease: randomised controlled trial. BMJ 2013; 346: f576. 10.1136/bmj.f576 PubMedWeb of Science®Google Scholar 5Kontis V, Bennett JE, Rashid T, et al. Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries. Nat Med 2020; 26(12): 1919–1928. 10.1038/s41591-020-1112-0 CASPubMedWeb of Science®Google Scholar 6Artusi CA, Imbalzano G, Sturchio A, et al. Implementation of Mobile health Technologies in Clinical Trials of movement disorders: underutilized potential. Neurotherapeutics 2020. https://doi.org/10.1007/s13311-020-00901-x 10.1007/s13311-020-00901-x PubMedWeb of Science®Google Scholar Citing Literature Volume36, Issue3March 2021Pages 531-532 ReferencesRelatedInformation